Allocations
Gravie, a specialist in defined contribution healthcare, has raised USD28 million in a Series D round of financing led by AXA Venture Partners (AVP), with participation from existing investors FirstMark Capital, Split Rock Ventures and Revelation Partners.
The capital will be used to fuel Gravie’s continued growth through investments in product and technology, sales and marketing, and expansion into new markets through new and existing distribution channels.
“We are excited to partner with AXA Venture Partners in our mission to heal our broken healthcare system,” says Abir Sen, co-founder and Executive Chairman of Gravie. “Over the past couple of years,
Commonfund Capitalhas closed Commonfund Venture Partners XIII (CVP XIII) at its hard cap of USD625 million. The oversubscribed fund had strong participation from existing investors, as well as select new institutional limited partners. Investors in the fund include foundations, endowments, pensions, healthcare systems and family offices.
“We are very appreciative of the continued support from our mission-driven and membership-based investors. The combination of our industry relationships, dedicated focus and access as well as our information advantages should enable us to support the innovation economy and drive returns for our investors,” says Aaron Miller, Managing Director and Head of Venture Capital.
Citizens M&A Advisory announced has served as the exclusive financial adviser to trustaff Management and CardioSolution on their recapitalisation by Cornell Capital and Trilantic North America, two New York-based private equity firms.
Founded in 2002, trustaff Management is a provider of travel nurse and allied healthcare staffing services while CardioSolution delivers a managed services offering providing cardiologists and support personnel to hospitals. Since inception trustaff has demonstrated industry-leading growth on its path to become one of the largest healthcare staffing firms in the country and a Top 5 provider of travel nurses. CardioSolution offers a differentiated service model that includes
Blue Point Capital Partners has acquired Weaver Leather, its ninth Blue Point IV platform investment.
Based in Mt Hope, Ohio, Weaver is a produces enthusiast brands in the equine, pet, leather crafting, arborist, livestock and construction markets. Known for its quality and breadth of products, Weaver manufactures, markets and distributes a broad line of branded and non-branded leather, nylon/synthetic, hardware and other products and accessories. The Company’s deep customer and supplier partnerships have enabled its history of growth and successful entry into new end markets and product categories. For over 45 years, Weaver’s core values, culture and management philosophy
Data in the report ‘Impact investing and the rise of sustainable tech’ shows that impact technology companies are receiving a fast-increasing amount of private equity investment. As the sector matures, those raises are becoming larger and focused on later-stage companies.
Eurazeo, via its Eurazeo PME subsidiary, has signed an exclusivity agreement under which it would invest, as a majority shareholder, alongside Groupe Premium’s current shareholders – Montefiore Investment, Groupe Premium’s management including Olivier Farouz, Laurent and Didier Zerbib, Benoît Jauvert and other key executives, together with independent agent partners.
The transaction would value Groupe Premium at EUR290 million and Eurazeo PME’s investment should be around EUR100 million, depending on the level of reinvestment by current shareholders.
Groupe Premium was founded in 2000 and is France’s leading independent broker for life insurance and retirement savings solutions aimed at the
Currencies Direct, a specialist in digital foreign exchange (FX) and international payment services to high value private clients and SMEs, has completed a GBP165 million dividend recapitalisation.
On-demand fulfilment start-up Cubyn has raised EUR35 million in a funding round led by Eurazeo and Bpifrance Large Venture, with new participation from First Bridge Ventures and Fuse Venture Partners, and follow-on funding from DN Capital, 360 Capital, Bpifrance Smart Cities fund and BNPP Développement.
Cubyn will use its new funding to double its team of 85 to 170+ employees by the end of 2021, and deploy its service internationally, starting with Spain and Portugal launching in April 2021 followed by Italy, UK and Germany. The company will also open a 25,000 sq m automated facility in the Paris area
Private Equity Wire’s PEWlive Healthcare Investing Summit brought together GPs, LPS and other private equity experts to share their insights into the fast-changing healthcare sector.
Humatica, a private equity specialist adviser for portfolio organisational effectiveness, has advised private equity firm Intermediate Capital Group (ICG) on its investment in Lucid Group.
Founded in 2007, Lucid Group is a strategic healthcare communications company committed to advancing patient health outcomes through healthcare communications that improve the way patients and diseases are managed, and medicines are used. Lucid Group’s pioneering approaches have received industry-wide recognition and have consistently led to above industry growth.
With offices in the UK, US and Asia, Lucid now employs around 250 people. Lucid works in partnership with the world’s leading pharmaceutical and biotech organisations
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
